Evidence map›Paper›PMID 32493978›Full record

ArticleScientific reports2020

Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities.

Takuhiro Sonoyama, Lukas K J Stadler, Mingyan Zhu, Julia M Keogh, Elana Henning, Fuki Hisama, Peter Kirwan, Magdalena Jura, Beata K Blaszczyk, David C DeWitt and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Neurotrophin signalling in the human nervous system.Frontiers in molecular neuroscience · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Takuhiro Sonoyama *University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Lukas K J Stadler *University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Mingyan ZhuIntegrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
Julia M KeoghUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Elana HenningUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Fuki HisamaDepartment of Medicine (Medical Genetics), University of Washington School of Medicine, Seattle, Washington, USA.
Peter KirwanUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Magdalena JuraUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Beata K BlaszczykDepartment of Biochemistry, 80 Tennis Court Road, CB2 1QW, University of Cambridge, Cambridge, UK.
David C DeWittIntegrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
Bas BrouwersUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Marko HyvönenDepartment of Biochemistry, 80 Tennis Court Road, CB2 1QW, University of Cambridge, Cambridge, UK.
Inês BarrosoMRC Epidemiology Unit, Addenbrooke's Hospital, Cambridge, UK.
Florian T MerkleUniversity of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Suzanne M AppleyardIntegrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
Gary A Wayman *Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA. waymang@wsu.edu.
I Sadaf Farooqi *University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK. isf20@cam.ac.uk.
University of Cambridge · GBAddenbrooke's Hospital · GBWashington State University · USMRC Epidemiology Unit · GBUniversity of Washington Medical Center · USWellcome Trust · GB

Funding

Integration of Peripheral and Central Appetite Signals by Brainstem NeuronsR01DK083452 · NIDDK · WASHINGTON STATE UNIVERSITY · PI APPLEYARD, SUZANNE M · 2009 to 2018
$2.9M
Leptin regulation of GABAergic synaptogenesis and excitation-inhibition balance during development: effects of maternal obesityR01HD092369 · NICHD · WASHINGTON STATE UNIVERSITY · PI WAYMAN, GARY ALLEN · 2018 to 2022
$2.0M
Control of Dendritic and Synaptic Development by Extracellular CuesR01MH086032 · NIMH · WASHINGTON STATE UNIVERSITY · PI WAYMAN, GARY ALLEN · 2010 to 2014
$1.8M
Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/5Medical Research Council MR/P501967/1NICHD NIH HHS R01 HD092369NIDDK NIH HHS R01 DK083452NIMH NIH HHS R01 MH086032Wellcome Trust 098497/Z/12/ZWellcome Trust 207462/Z/17/ZWellcome Trust 208363/Z/17/ZWellcome Trust 211221/Z/18/Z
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) signals through its high affinity receptor Tropomyosin receptor kinase-B (TrkB) to regulate neuronal development, synapse formation and plasticity. In rodents, genetic disruption of Bdnf and TrkB leads to weight gain and a spectrum of neurobehavioural phenotypes. Here, we functionally characterised a de novo missense variant in BDNF and seven rare variants in TrkB identified in a large cohort of people with severe, childhood-onset obesity. In cells, the E183K BDNF variant resulted in impaired processing and secretion of the mature peptide. Multiple variants in the kinase domain and one variant in the extracellular domain of TrkB led to a loss of function through multiple signalling pathways, impaired neurite outgrowth and dominantly inhibited glutamatergic synaptogenesis in hippocampal neurons. BDNF/TrkB variant carriers exhibited learning difficulties, impaired memory, hyperactivity, stereotyped and sometimes, maladaptive behaviours. In conclusion, human loss of function BDNF/TrkB variants that impair hippocampal synaptogenesis may contribute to a spectrum of neurobehavioural disorders.

Indexed as

AdolescentBrain-Derived Neurotrophic FactorChildChild, PreschoolFemaleHippocampusHumansMaleNeurogenesisNeuronal OutgrowthNeuronsPhosphorylationProtein KinasesReceptor, trkBSignal TransductionBDNF protein, humanBrain-Derived Neurotrophic FactorProtein KinasesReceptor, trkBtropomyosin kinase

Identifiers

PMID32493978
PMCPMC7270116
OpenAlexW3029566839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.